Vedere Bio II, Inc.® is a company developing next generation ocular gene therapies designed for vision restoration and preservation for patients with vision loss due to photoreceptor death.
Company Details
- Founded
- 2020
- Address
- 400 Technology Square,
- Phone
- (857) 201-2700
- in****@****bio.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- vederebio.com
- HQ
- Cambridge, MA
Vedere Bio Ii Questions
Vedere Bio Ii's helpline number is (857) 201-2700
Vedere Bio Ii's website is vederebio.com
Vedere Bio Ii's LinkedIn profile is https://www.linkedin.com/company/vedere-bio
Vedere Bio Ii's industry is
Biotechnology Research
Vedere Bio Ii's top competitors are
Rectify Pharma,
Bluebird Bio,
Calluna Pharma,
Vesigen Therapeutics, Inc.,
Pheon Therapeutics,
Disc Medicine,
Decibel Therapeutics,
Aavantgarde,
Tessera Therapeutics,
Beam Therapeutics.
Vedere Bio Ii's support email address is info@vederebio.com
Vedere Bio Ii's categories are Biotechnology Research
Vedere Bio Ii's founding year is 2020
